eFlow

PARI Pharma, a subsidiary of the PARI Group, is a specialized medical device and drug delivery company focused on the development of advanced aerosol delivery systems. The company is best known for its proprietary eFlow Technology, an electronic vibrating mesh nebulizer platform designed to provide fast, efficient, and silent delivery of liquid medications to the lungs. PARI Pharma operates a unique business model by partnering with pharmaceutical companies to develop drug-specific versions of the eFlow device, optimized for specific therapeutic agents. Their portfolio includes several approved drug-device combination products used primarily in the treatment of chronic respiratory diseases such as cystic fibrosis and bronchiectasis.